Pdt Partners, LLC Care Dx, Inc. Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

A detailed history of Pdt Partners, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 16,125 shares of CDNA stock, worth $345,397. This represents 0.05% of its overall portfolio holdings.

Number of Shares

16,125

Holding current value

$345,397

% of portfolio

0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$14.41 - $33.99 $232,361 - $548,088	16,125 New	16,125 $503,000
Q3 2023 Nov 14, 2023	SELL	$7.0 - $11.26 $229,901 - $369,812	-32,843 Reduced 24.76%	99,797 $698,000
Q2 2023 Aug 14, 2023	BUY	$7.61 - $9.46 $1.01 Million - $1.25 Million	132,640 New	132,640 $1.13 Million
Q1 2022 May 16, 2022	SELL	$28.19 - $46.6 $1.48 Million - $2.44 Million	-52,355 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$41.2 - $73.6 $846,454 - $1.51 Million	-20,545 Reduced 28.18%	52,355 $2.38 Million
Q3 2021 Nov 15, 2021	BUY	$59.15 - $91.99 $814,199 - $1.27 Million	13,765 Added 23.28%	72,900 $4.62 Million
Q2 2021 Aug 16, 2021	SELL	$63.02 - $95.11 $152,193 - $229,690	-2,415 Reduced 3.92%	59,135 $5.41 Million
Q1 2021 May 17, 2021	SELL	$57.62 - $95.6 $944,507 - $1.57 Million	-16,392 Reduced 21.03%	61,550 $4.19 Million
Q4 2020 Feb 16, 2021	SELL	$41.43 - $77.09 $854,162 - $1.59 Million	-20,617 Reduced 20.92%	77,942 $5.65 Million
Q3 2020 Nov 16, 2020	BUY	$30.88 - $37.94 $315,902 - $388,126	10,230 Added 11.58%	98,559 $3.74 Million
Q2 2020 Aug 14, 2020	SELL	$18.95 - $35.43 $611,535 - $1.14 Million	-32,271 Reduced 26.76%	88,329 $3.13 Million
Q1 2020 May 15, 2020	BUY	$13.94 - $28.25 $546,406 - $1.11 Million	39,197 Added 48.15%	120,600 $2.63 Million
Q4 2019 Feb 14, 2020	BUY	$19.24 - $28.41 $885,020 - $1.31 Million	45,999 Added 129.93%	81,403 $1.76 Million
Q3 2019 Nov 14, 2019	SELL	$20.03 - $40.08 $909,281 - $1.82 Million	-45,396 Reduced 56.18%	35,404 $800,000
Q2 2019 Aug 14, 2019	BUY	$25.78 - $39.77 $491,005 - $757,459	19,046 Added 30.84%	80,800 $2.91 Million
Q1 2019 May 15, 2019	BUY	$22.09 - $39.21 $927 - $1,646	42 Added 0.07%	61,754 $1.95 Million
Q4 2018 Feb 14, 2019	BUY	$19.89 - $30.02 $238 - $360	12 Added 0.02%	61,712 $1.55 Million
Q3 2018 Nov 14, 2018	BUY	$12.1 - $28.85 $746,570 - $1.78 Million	61,700 New	61,700 $1.78 Million
Q2 2018 Aug 14, 2018	SELL	$7.93 - $15.79 $181,914 - $362,222	-22,940 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$5.18 - $7.97 $118,829 - $182,831	22,940 New	22,940 $183,000

Others Institutions Holding CDNA

# of Institutions

218

Shares Held

51.1M

Call Options Held

97.3K

Put Options Held

43.3K

Black Rock Inc. New York, NY

5.29M
Shares

$113 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.54M
Shares

$97.2 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.15M
Shares

$67.4 Million
1.65% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

2.99M
Shares

$64 Million
0.89% of portfolio
State Street Corp Boston, MA

2.04M
Shares

$43.6 Million
0.0% of portfolio

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account